Integration vs. Innovation: Is Bigger Really Better?
Executive Summary
Before jumping on the M&A bandwagon, pharmaceutical companies should examine four key issues: Is consolidation a long-term trend? Does size matter? Do horizontal combinations create value? If so how does it compare with value through innovation?